Myriad Genetics Inc (NAS:MYGN)
$ 26.84 0.45 (1.71%) Market Cap: 2.44 Bil Enterprise Value: 2.44 Bil PE Ratio: 0 PB Ratio: 3.29 GF Score: 78/100

Q4 2020 Myriad Genetics Inc Earnings Call Transcript

Aug 13, 2020 / 08:30PM GMT
Release Date Price: $13.38 (+2.37%)
Operator

Greetings, and welcome to the Myriad Genetics Fourth Quarter 2020 Financial Earnings Call. (Operator Instructions) And as a reminder, this conference is being recorded, Thursday, August 13, 2020.

I'd now like to turn it to Scott Gleason, VP, Investor Relations. Please go ahead.

Scott Gleason
Myriad Genetics, Inc. - SVP of IR

Thanks, Keith. Good afternoon. Welcome to the Myriad Genetics Fourth Quarter 2020 Earnings Call. During the call, we will review the financial results we released today, after which we will host a question-and-answer session. If you have not had a chance to review our quarterly earnings release, it can be found on our website at myriad.com.

I am Scott Gleason, the Senior Vice President of Investor Relations and Corporate Strategy. And on the call with me today will be Paul Diaz, our newly announced President and Chief Executive Officer; and Bryan Riggsbee, our Chief Financial Officer. This call can be heard live via webcast at myriad.com, and a recording will be archived in the Investors section of our website. In

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot